Page last updated: 2024-10-27

fenofibrate and B16 Melanoma

fenofibrate has been researched along with B16 Melanoma in 3 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, YC1
Liu, KC1
Chiou, YL1
Yang, CH1
Chen, TH1
Li, TT1
Liu, LL1
Grabacka, M2
Wieczorek, J1
Michalczyk-Wetula, D1
Malinowski, M1
Wolan, N1
Wojcik, K1
Plonka, PM2
Placha, W1
Pajak, S1
Urbanska, K1
Laidler, P1
Slominski, A1

Other Studies

3 other studies available for fenofibrate and B16 Melanoma

ArticleYear
Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway.
    Chemico-biological interactions, 2013, Oct-05, Volume: 205, Issue:3

    Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Fenofibrate; Humans; Imidazoles; MAP Kinase Sign

2013
Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Archives of dermatological research, 2017, Volume: 309, Issue:3

    Topics: Acetylation; Animals; Cell Line, Tumor; Cell Proliferation; Fenofibrate; Hypolipidemic Agents; Melan

2017
Inhibition of melanoma metastases by fenofibrate.
    Archives of dermatological research, 2004, Volume: 296, Issue:2

    Topics: Animals; Antineoplastic Agents; Base Sequence; Cricetinae; Female; Fenofibrate; Hypolipidemic Agents

2004